I don’t agree that they are waiting for severe results for mild to moderate. When you think about it why even do a mild to moderate trial? If Leronlimab helps 2 completely different populations GREAT but one really has nothing to do with the other if they were that alike we would be running 2 different trials and recruiting 2 completely different stages of progression. In one trial we’re trying to stop from ending up on ventilators and death beds and in the other trial were trying to bring back to life people in there death beds ventilators and ECMO. We should have got a phase 3 2+ weeks ago if they were waiting for CD-12